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Polychlorinated biphenyls (PCBs) and 1,1-
bis(4-chlorophenyl)-2,2-dichloroethene
(p,p'-DDE) are among the most widely
spread environmental contaminants known.
PCBs have mainly been used as plasticizers,
dielectric fluids, and hydraulic oils. They
were first detected in awhite-tailed sea eagle
in 1966 (1) and soon after were detected in
human milk (2). In Sweden the use ofPCBs
was restricted in 1972 and was fully phased-
out in 1995. Despite worldwide restrictions
of these compounds, PCBs are still distrib-
uted to the environment and circulate
between different compartments of the sys-
tem. The persistence and lipophilic charac-
ter ofPCBs lead to their ubiquitous distrib-
ution as environmental contaminants [e.g.,
found in blood (3) and mother's milk (4)].
DDE is a metabolite of 2,2-bis(4-
chlorophenyl)-1, 1, 1-trichloroethane
(DDT), which was a commonly used insec-
ticide from the 1940s to the 1960s. In
Sweden the use ofDDT as an insecticide in
homes, gardens, and agriculture was pro-
hibited in 1970, with an exception made
for use on conifer plants until 1974.
However, this pesticide is still used in cer-
tain countries, particularly where malaria is
aproblem ofgreat concern (5).
In animals, lipophilic compounds are
usually metabolized to more hydrophilic
compounds that are more easily excreted
than the parent substances. Metabolites of
persistent environmental contaminants,
however, may also have hydrophobic prop-
erties and can thus be accumulated in
body, such as methyl sulfone metabol
of chlorinated biphenyls (MeSO2-C
and of DDE (MeSO2-DDE) (6,7),
they may have specific protein-bind
properties, such as certain MeSO2-C
(8-11), hydroxy-CBs (12), and MeS(
DDE (13,14). These properties lead to
retention of certain MeSO2-CBs in lu
kidney, and uterine fluid (8-10) a
MeSO2-DDE in adrenal tissue (13,14).
A major metabolic pathway ofarom;
organochlorine compounds proceeds
P450-mediated formation of arene ox
intermediates, with subsequent format
of either hydroxylated metabolites or n
capturic acid pathway (MAP) metabol
after reaction between glutathione and
epoxide (15-17). The cysteine conjug.
formed via MAP may form aryl thiols (
to C-S lyase-induced cleavage of the C
bond in the conjugate (16). The aryl td
formed is enzymatically methylated a
then subsequently oxidized to the co]
sponding aryl methyl sulfone (15,16).
structures of the formed compounds
exemplified by 3-MeSO2-DDE, 4-MeS(
CB149, and 3-MeSO2-CB149 (Fig. 1).
As environmental contaminar
MeSO2-PCBs and MeSO2-DDE were i
identified in seal blubber from the Ba
(6). Since then such metabolites have b
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this and other parts of the wo
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PCBs were first reported in adipose tissue
ed and milk from a woman exposed to PCBs
be in a capacitor factory in Japan (19).
|E MeSO2-PCBs and MeSO2-DDE were also .., ..,. ,.................
identified in adipose, liver, and lung tissue
ii from Yusho patients as well as in a control
it- person (20-23).
mo Considering these results and the fact
%g that PCBs and DDE are major environ- t2;. mental contaminants present in human
8: milk in Sweden, it is of interest to investi-
i- gate the occurrence of methyl sulfone
es metabolites of PCBs and DDE in human
il- milk. The aim of the present study was to
3- develop a method for simultaneous analysis
'- ofPCB (and other chlorinated compounds)
...... and its methylsulfonyl metabolites and to
W determine the concentrations ofthese com-
pounds in human milk sampled during dif-
ferent time periods to visualize any trends
over time for the PCB and DDE methyl
the sulfones.
ites The methods used to isolate aryl methyl
Bs) sulfones include liquid-liquid partitioning
or (6,18,24) and various chromatographic
ing methods (7,18,20,25). The final analyses
'-Bs are primarily performed by GC electron-
02- capture detection (e.g., 7,18,20,24), mass
the spectrometry in electron ionization (El)
ng, (25), or negative ion chemical ionization
nd mode (27), but recently detection by GC
atomic emission detector was described
atic (28). Our work is discussed here in relation
via to these analytical procedures.
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Several ofthe archived samples were pooled
by mixing equal amounts of samples from
the same time period. The average age of
the women in the pools was 27-28 years,
except for 1992 when the average age was
29 years. In each period, 55-60% of the
women who supplied milk were nursing
their first infant. The majority of the rest
were nursing their second child.
Methanol, n-hexane, acetonitrile,
dichloromethane, and trichloromethane
were of HPLC-grade (Rathburn, Walke-
burn, Scotland) and were redistilled before
use. Formic acid was ofpro analysi quality
(Merck, Darmstadt, Germany). Water was
deionized and purified with a Milli Q car-
tridge system (Millipore, Bedford,
Massachusetts). The MeSO2-CBs used as
standard compounds are listed in Table 1.
The synthesis ofthese compounds has been
described elsewere (29-30). 3-MeSO2-4,4'-
DDE was synthesized as desribed by
Bergman and Wachtmeister (31). 3-
Methylsulfonyl-4-methyl-5,2',3',4',5'-pen-
tachlorobiphenyl was used as an internal
standard. The Lipidex 5000 gel was from
Packard Instruments (Downers Grove,
Illinois). The Lipidexwaswashed and stored
in methanol at 40C (32). Immediately
before use, the gel was rinsed with
methanol in a separating funnel equipped
with a sintered-glass disc and a polytetraflu-
oroethylene stopcock. For a 20-g portion of
Lipidex, 2 x 25 ml of methanol was used.
Most ofthe remaining methanol in the gel
was removed with a gentle stream ofnitro-
gen applied from the top ofthe funnel. The
nitrogen, quality 5.5 fromAGA (Stockholm,
Sweden) was purified with moisture and
oxygen filters (Chrompack, Middelburg,
The Netherlands). Aluminum oxide 90
(activity grade II-III) from Merck was acti-
vated at 8000C for 4 hr and partly deacti-
vated by adding water, corresponding to a
concentration of 5% water (w/w). Bio-
Beads S-X3, 200-400 mesh, was purchased
from Bio-Rad Laboratories (Richmond,
California).
All glasswarewaswashedwith detergents
in an ultrasonic bath and rinsed thoroughly
with tap water, deionized water and Mili Q
water and then heated overnight at 280°C.
The glassware was rinsed with hexane before
use. The glass chromatographic columns
usedhadIDof2and 1 cm.
GC/MS analyses were performed with
a VG 70-250 mass spectrometer equipped
with an HP 5890A gas chromatograph and
a VG-250 data system (VG Analytical,
Manchester, UK). Gas chromatography
was performed using a fused silica SE-54
capillary column (25 m x 0.32 mm ID,
0.25-tim film thickness; Quadrex, New
Haven, Connecticut) with helium as a car-
rier gas. An all-glass falling needle injector
was used with an injector temperature at
270°C. The oven temperature was 1900C
for 0.1 min, programmed to 2300C at
5°C/min, hold for 0.2 min, programmed
to 235°C at 1°C/min, hold for 3 min, pro-
grammed to 2700C at 9°C/min, and hold
for 8 min. EI was performed in an "EI-
only" ion source at the electron energy of
31 eV and the trap current of500 pA. The
source temperature was 2600C. The accel-
eration voltage was 6 kV and the resolution
at m/z 293 was 7000-9000. The MS was
operated in a selected ion recording mode.
Figure 1. Structures of3-MeSO2-DDE, 4-MeSO2-CB149, and 3-MeSO2-CB149.
Table 1. Structures ofthe MeSO2-CBs analyzed and their parent compounds
Methyl sulfones
3-MeSO2-2,5,2',4'-tetraCB (3-49)a
4-MeSO2-2,5,2',4'-tetraCB (4-49)
3-MeSO2-2,5,2',5'-tetraCB (3-52)
4-MeSO2-2,5,2',5'-tetraCB (4-52)
3-MeSO2-2,5,6,4'-tetraCB (3-64)
4-MeSO2-2,3,6,4'-tetraCB (4-64)
3-MeSO2-2,5,3',4'-tetraCB (3-70)
4-MeSO2-2,5,3',4'-tetraCB (4-70)
3-MeSO2-2,5,2',3',4'-pentaCB (3-87)
4-MeSO2-2,5,2',3',4'-pentaCB (4-87)
3-MeSO2-2,5,6,2',4'-pentaCB (3-91)
4-MeSO2-2,3,6,2',4'-pentaCB (4-91)
3-MeSO2-2,5,2',4',5'-pentaCB (3-101)
4-MeSO2-2,5,2',4',5'-pentaCB (4-101)
3-MeSO2-2,5,6,3',4'-pentaCB (3-110)
3-MeSO2-2,5,6,2',3',4'-hexaCB (3-132)
4-MeSO2-2,3,6,2',3',4'-hexaCB (4-132)
3-MeSO2-2,5,2',3',4',5'-hexaCB (3-141)
4-MeSO2-2,5,2',3',4',5'-hexaCB (4-141)
3-MeSO2-2,5,6,2',4',5'-hexaCB (3-149)
4-MeSO2-2,3,6,2',4',5'-hexaCB (4-149)
3-MeSO2-2,5,6,2',3',4',5'-heptaCB (3-174)
4-MeSO2-2,3,6,2',3',4',5'-heptaCB (4-174)
Parent compound
2,4,2',5'-tetraCB (CB-49)
2,4,2',5'-tetraCB (CB-49)
2,5,2',5'-tetraCB (CB-52)
2,5,2',5'-tetraCB (CB-52)
2,3,6,4'-tetraCB (CB-64)
2,3,6,4'-tetraCB (CB-64)
2,5,3',4'-tetraCB (CB-70)
2,5,3',4'-tetraCB (CB-70)
2,3,4,2',5'-pentaCB (CB-87)
2,3,4,2',5'-pentaCB (CB-87)
2,3,6,2',4'-pentaCB (CB-91)
2,3,6,2',4'-pentaCB (CB-91)
2,4,5,2',5'-pentaCB (CB-101)
2,4,5,2',5'-pentaCB (CB-101)
2,3,6,3',4'-pentaCB (CB-110)
2,3,4,2',3',6'-hexaCB (CB-132)
2,3,4,2',3',6'-hexaCB (CB-132)
2,3,4,5,2',5'-hexaCB (CB-141)
2,3,4,5,2',5'-hexaCB (CB-141)
2,3,6,2',4',5'-hexaCB (CB-149)
2,3,6,2',4',5'-hexaCB (CB-149)
2,3,4,5,2',3',6'-heptaCB (CB-174)
2,3,4,5,2',3',6'-heptaCB (CB-174) Figure 2. Scheme of method for analysis of aryl
methyl sulfones.
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Table 2. Recoveries of aryl methyl sulfones added to milk
Amount added
MeSO2-CB (ng/mI) n Range (%)
3-49 0.41-0.75 7 71-118
4-49 0.42-0.81 7 77-110
3-52 0.41 6 80-113
4-52 0.42 6 80-93
3-64 0.41 6 79-100
4-64 0.12-0.41 7 80-98
3-70 0.19-0.42 7 80-95
4-70 0.41 6 75-104
3-87 0.41-1.52 7 72-96
4-87 0.41-2.12 5 78-102
3-91 0.42-0.49 7 69-107
4-91 0.42 6 81-102
3-101 0.40-4.19 5 81-97
4-101 0.41-1.47 5 79-101
3-110 0.08-0.41 7 73-96
3-132 0.41 7 75-101
4-132 0.41-1.02 7 72-88
3-141 0.40 6 71-100
4-141 0.41 6 73-108
3-149 0.41-0.75 7 78-110
4-149 0.41-1.13 5 81-109
3-174 0.40 6 63-97
4-174 0.41 6 66-98
MeSO2-DDE 0.44-1.34 7 69-89
Internal standard 0.42 7 74-100
Table 3. Levels of MeSO2-CBs and MeSO2-DDE in human milk (ng/g Ii
Year
Compound 1972(75)' 1976(153) 1980(199) 1984/85(102)
3-49
4-49
3-52
4-52
3-64
4-64
3-70
4-70
3-87
4-87
3-91
4-91
3-101
4-101
3-110
3-132
4-132
3-141
4-141
3-149
4-149
3-174
4-174
0.14
0.46
0.07
0.06
0.03
0.10
0.12
0.09
0.15
2.13
0.21
0.12
0.20
0.78
0.04
0.08
0125
0.11
0.63
1.23
2.00
0.09
0.15
0.10
0.34
0.05
0.06
0.08
0.10
0.09
0.11
0.12
2.09
0.17
0.08
0.17
0.64
0.07
0.06
0.15
0.09
0.56
0.80
1.87
0.09
0.09
0.06
0.26
0.01
0.02
0.06
0.05
0.07
0.07
0.10
1.20
0.11
0.04
0.16
0.52
0.03
0.04
0.07
0.04
0.34
0.48
0.70
0.08
0.05
0.04
0.16
0.01
0.01
0.03
0.02
0.04
0.03
0.06
0.70
0.08
0.02
0.15
0.32
0.02
0.03
0.05
0.12
0.19
0.34
0.64
0.03
0.02
3-MeSO2- 5.05 2.80 1.81 0.79
DDE
MeSU2-DDE/ 0.002
DDE
MOSO2PCB/ 0.009
PCB
MeSO -PCB/ 0.04
CB-15l
1011 1151 ~500
it #11 ~~~~~-600
0.002 0.002 0.002
0.009 0.006 0.005
0.04 0.03 0.03
aNumber of women in parentheses.
For each compound, two ions ofthe mole-
cular ion cluster were monitored. Ions
Recoveryge Relative SD from perfluorokerosene were used as refer-
Average (%) Relative SD (%) ence masses for correction of mass spec-
86 14 trometer drift (lock mass).
90 10 A scheme of the analytical method is
90 11 shown in Figure 2.
87 4 Extraction. The extraction was per-
88 7
87 7 formed as previously described for multi-
87 7 component analysis oforganochlorine cont-
90 9 aminants in human milk (33). A sample of
87 8 milk (10 ml) was weighed into a flask with
89 12 a Teflon-lined screw cap. Internal standard
93 8 (100 pl of 41.4 pg 3-methylsulfonyl-4-
92 6 methyl-5,2',3',4',5'-pentachloro-
94 9 biphenyl/pl) was added and thoroughly
89 9 mixed with the milk. Then, formic acid (10
84 7 ml) was added and finally Lipidex 5000
86 13 (5.0 g). The mixture was shaken at 35°C
85 11 for 2.5 hr and then transferred to a glass
93 11 column (2 cm ID). The solvent was drained
87 12 and, in consecutive steps, was washed with
87 10 30% methanol (40 ml) and 50% methanol
80 7 (40 ml). Organochlorine compounds and
84 8 some of the lipids were eluted by acetoni-
trile (75 ml). Remaining lipids were eluted
pids) by trichloromethane/methanol/hexane
(1:1:1 byvol, 60 ml).
Lipiddeternination. The two fractions
1990(40) 1991 (40) 1992(20) containing lipids were taken nearly to dry-
0.02 0.03 0.01 ness in a rotary evaporator at 35°C and dried
0.10 0.12 0.05 to constant mass in a desiccator containing
<0.01 0.01 0.01 silica gel. The sum ofthe residue, gravimetri-
0.01 0.03 0.01 cally determined, of the two fractions
0.02 0.01 0.01 defined the amount offat in the sample.
0.04 0.03 0.01 Punficaton andseparation. Aluminum
0.15 0.05 0.01 oxide (5 g) was packed in a column (1 cm
0.05 0.02 0.04 ID) and washed with hexane (10 ml). Then
0.94 0.67 0.33 the stopcock was closed and the residue
0.03 0.02 0.02 from acetonitrile fraction was quantitatively
0.12 0.09 0.08 transferred to the column with small por-
0.33 0.28 0.13 tions ofhexane. The sample on the column
0.02 0.01 0.01 was concentrated by evaporation ofthe sol-
0.04 0.01 0.03 vent with a gentle stream of nitrogen.
0.06 0.01 0.02 Organochlorine compounds, such as pesti-
0.25 0.14 0.11 cides, PCBs, polychlorinated naphthalenes,
0.41 0.20 0.24 polychlorinated dibenzo-p-dioxins andpoly-
1.00 0.59 0.35 chlorinated dibenzofurans, were eluted by
<0.03 0.04 0.02 hexane (10 ml) and f-hexachlorocyclohexa-
00
ne (0-HCH) and dieldrin in an additional
.,....366 - -- - fraction ofhexane (20 ml). Al MeSO -CBs
0.64 0.40 DAB6 third fraction, collected when 50%
dichloromethane in hexane (20 ml) was
37 ,!5. used as a mobile phase.
150 ~ ~ ~~~M. Bio-Beads S-X3 (5 g) were transferred to
o .. v -a beaker and dichlorometbane/hexane (1:1,
0.002 0.002 0.002 v/v) was added to cover the gel. The beaker
was placed in an ultrasonic bath for a few
0.006 0.005 0.004 seconds and then letequilibrate for 2 hr. The
mixture was subsequently transferred to a
0.03 0.02 0.02 column (1 cm ID). The solvent was drained
and the gel was washed with dichloro-
methane/hexane (1:1, v/v, 20 ml). The vol-
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ume ofMeSO2-CBs and MeSO2-DDE-con-
taining fraction was adjusted by evaporation
to about 0.5 ml, transferred to a small,
tapered centrifuge tube, concentrated to
about 50 il with nitrogen, and then quanti-
tatively transferred with small volumes of
dichloromethane/hexane (1:1) to the GPC
column (Bio-Beads S-X3). The mobile
phase, dichloromethane/ hexane (1:1), was
collected at a rate of20 drops/min. The first
15 ml were discarded. The following 9 ml
contained MeSO2-CBs and MeSO2-DDE.
To purify the column from contaminants, it
was washed with an additional 25 ml ofthe
solvent mixture and discarded. The fraction
containing MeSO2-CBs and MeSO2-DDE
was concentrated to 50 pl and transferred
quantitatively to the same column, and the
procedure was repeated. The fraction con-
taining MeSO2-CBs and MeSO2-DDE (9
ml) from this second fractionation was con-
centrated and about half of the sample was
used foranalysis byGC-MS.
Recovery studies. Recovery studies were
performed by adding 50-100 pl of stan-
dard mixtures in hexane of MeSO2-CBs
(see Table 1), 3-MeSO2-DDE and 3-
methylsulfonyl-4-methyl-5,2',3',4',5'-pen-
tachlorobiphenyl (the internal standard
used) to the sample before extraction.
Before determination by GC-MS,
2,3,4,5,2',3',4'-heptaCB (CB-170) (34)
was added as an internal standard for vol-
ume correction.
Results
The congener-specific analyses of MeSO2-
CBs and MeSO2-DDE were made by
GC-MS using an "EI-only" ion source. At
a resolution of7000 and the electron ener-
gy of 31 eV, the detection limits of the
compounds listed in Table 1 were 0.5-2 pg
at S/N 2.5. Considerably lower sensitivity
was obtained at 70 eV (detection limit
2-10 pg). In the investigation ofmilk, the
detection limits of MeSO2-CBs and
MeSO2-DDE were 0.01-0.05 ng/glipid.
The mean recoveries of MeSO2-CBs
and MeSO2-DDE added to the samples
before extraction were 80-97% and of
internal standard were 84% (Table 2).
Congener-specific analyses of MeSO2-CBs
and MeSO2-DDE in human milk collected
in different years, starting from 1972, were
performed. The concentrations ofMeSO2-
CBs and MeSO2-DDE are shown in Table
3. Of the metabolites studied, 3-MeSO2-
DDE had the highest concentration. The
level of 3-MeSO2-DDE was about 5 ng/g
fat in milk from 1972 and declined succes-
sively with time to about 0.4 ng/g fat in
1991-1992. A decline in the concentra-
tions of p,p'-DDT and p,p'-DDE in
Swedish human milk has been demonstrat-
2500 -
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Figure 3. Concentrations ofp,p'-DDE and p,p'-DDE methyl sulfone in human milk, 1972-1992.
ed previously (35,36). The concentrations
ofp,p'-DDT and p,p'-DDE in the present
samples are shown in Table 3. There is a
good correlation between the concentra-
tions of 3-MeSO2-DDE and correspond-
ing decline in the concentration ofp,p'-
DDE (correlation coefficient of 0.99; Fig.
3). The ratio of the concentrations of 3-
MeSO2-DDE top,p'-DDE was 0.002.
All the MeSO2-CBs shown in Table 1
were identified in human milk. The profile
ofthe MeSO2-CBs was similar in the milk
sampled in different years, but the concen-
trations changed with time. The most
abundant MeSO2-CB was compound 4-87,
originating from 2,3,4,2',5'-pentaCB (CB-
87), followed by 4-149, originating from
2,3,6,2',4',5'-hexaCB (CB-149). The com-
pounds with methylsulfonyl group in posi-
tion 4 (para) occur at higher levels than the
corresponding compounds with methylsul-
fonyl group in position 3 (meta) (Fig. 4).
The MeSO2-CBs in human milk origi-
nate from CBs that do not occur at high
levels in milk. Of the precursors, only
2,5,2',5'-tetraCB (CB-52) and 2,4,5,2',5'-
pentaCB (CB-101) were found in milk (to
be published). The concentrations of
MeSO2-CBs decreased from 9.2 ng/g lipids
in 1972 to 1.6 ng/glipids in 1992 (Table 3)
and correlated to the decline in the levels of
total CBs by a correlation coefficient of
0.95 (Fig. 5). The total CB levels were
determined by EC-GC using a packed col-
umn (35,36; in preparation). The ratios of
the sum of MeSO2-CBs (MeSO2-PCB) to
total CB (PCB) concentration decreased
from 0.009 to 0.004 during the time course
studied (Table 3). Comparisons were also
made to 2,4,5,2',4',5'-hexaCB (CB-153),
determined by congener specific analysis.
This PCB congener does not contain adja-
cent, unsubstituted carbon atoms suscepti-
ble to metabolic reactions. Accordingly, it
has a long half-life (37) and is the most
abundant PCB congener in the human
milk. The decline of MeSO2-CBs relative
to CB-153 indicates a somewhat more
rapid dedine of MeSO2-CBs in milk than
ofPCB over the course ofthis time period.
Discussion
The analytical methods used in previously
reported investigations ofMeSO2-CBs and
MeSO2-DDE involve several steps of liq-
uid-liquid partitioning and column chro-
matography (6,7,18,20,24,25). The aryl
methyl sulfones were extracted from tissue
samples by nonpolar solvents or medium-
polarity mixtures of solvents (6,24,25,38).
Different combinations of methods have
been used for purification and separation
from other organochlorine compounds,
e.g., chromatography (Bio-Beads, silica gel,
aluminum oxide) and partitioning between
solvents of different polarity, e.g., between
hexane and aqueous acetonitrile (24) and
between hexane and dimethyl sulfoxide
with subsequent reextraction ofthe analytes
with methyl tert-butyl ether:hexane, after
dilution of the dimethyl sulfoxide phase
with water (7). Because MeSO2-CBs and
MeSO2-DDE possess the character of a
Lewis base, partitioning between hexane
and concentrated sulfuric acid has frequent-
ly been used as a method for purification of
these compounds. However, a method
using exclusively chromatographic fraction-
ations (gel permeation, silica gel modified
with KOH, Florisil, and basic aluminum
oxide) for separation of the methyl sulfone
derivatives was recentlyreported (39).
In the present study the extraction pro-
cedure for MeSO2-CBs and MeSO2-DDE
from milk differs from the previously
decribed methods. Instead of partitioning
between solvents, the extraction was
accomplished by partitioning between the
milk-formic acid mixture and a lipophilic
gel, Lipidex 5000. The extraction between
an aqueous solution and Lipidex resembles
the extraction with a solvent of medium
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Figure 4. Concentrations of individual MeSO2-CBs in human milk from 1972-1992. (A) Compounds with four
chlorine atoms in the molecule, (B) compounds with five chlorine atoms, and (C) compounds with six to
seven chlorine atoms.
polarity. The advantage is that the proce-
dure can be done in one step. The column
bed can subsequently be eluted with sol-
vents of different polarity, facilitating par-
tial separation of lipids and an initial
purification of the analyte fraction. By this
procedure about 60% of the lipids in the
milk sample were separated from the ana-
lytes. In addition two chromatographic sys-
tems, aluminum oxide and Bio-Beads S-X3
were used. By repeating the gel permeation
step once, sufficiently clean extracts were
obtained for GC-MS analysis.
The recoveries of added MeSO2-CBs
and MeSO2-DDE (mean 80-97%) with a
relative standard deviation of 4-14%
(Table 2) were considered satisfactory for
the analysis using a small sample size (10
ml milk).
In the milk samples, 3-MeSO2-DDE
was the major aryl methyl sulfone com-
pound (about 5-0.4 ng/g lipids), whereas
only traces could be discerned of 2-
MeSO2-DDE. The ratio of MeSO2-
DDE/DDE (0.002) was constant in the
samples from different years. In Japanese
human samples (adipose, lung and liver tis-
sue) the ratios were somewhat higher
(0.007-0.009). A high species-specific
organ selectivity has been demonstrated for
MeSO2-DDE in wild animals (7), but no
concentrations in milk from these animals
or in human milk have previously been
reported. The present results are in accor-
dance with the observations that MeSO2-
DDE is the major aryl methyl sulfone in
Swedish human adipose tissue (40).
However, high concentration of2-MeSO2-
DDE and 3-MeSO2-DDE (about 0.9 and
0.4 pg/g fat, respectively) were reported in
the liver of polar bear (Canada). In grey
seal the levels were higher in the liver than
in adipose tissue, and the levels of 2-
MeSO2- and 3-MeSO2-DDE were equal.
In otter and mink, no 2-MeSO2-DDE was
detected and the levels of 3-MeSO2-DDE
were about equal in liver and muscle, cal-
culated on lipid weight basis (7). The
results indicate differences in exposure
and/or metabolism.
MeSO2-DDE is a potent toxicant for
the adrenal cortex in mouse (13) and also
in the human adrenal glands as observed as
in vitro bioactivation of this compound in
human adrenal gland (14). The irreversible
binding ofMeSO2-DDE in the zona fasci-
culata of the adrenals led to the formation
ofnecrotic cells and inhibition ofglucocor-
ticoid hormone synthesis (13,41). Also,
p,p'-DDE was recently reported to be a
strong androgen receptor antagonist (42);
the potency of the corresponding MeSO2-
DDE is not yet known. Due to the poten-
tial toxicity of DDE and MeSO2-DDE, it
is necessary to reduce the exposure to
DDT/DDE, especially in areas where
DDT is still used.
Generally, the precursors to the
MeSO2-CBs were not found in the milk,
indicating an effective metabolism of the
precursor CBs. The MeSO2-CBs originate
from CBs with chlorine atoms in 2,5- or
2,3,6-positions ofat least one ofthe phenyl
rings of the PCB congener (8). In these
compounds there are unsubstituted
metaIpara positions adjacent to two chlo-
rine atoms. This strongly facilitates the
reaction between the PCB arene oxide and
glutathione and formation of the two iso-
meric 3- and 4-MeSO2-PCBs, as observed
in minks dosed with a technical prepara-
tion ofthe PCB ClophenA50 (43).
In milk, the PCB metabolites with the
MeSO2 group in the 4-position are present
at higher concentrations than the corre-
sponding compounds with the MeSO2
group in 3-position, except for 3-91, which
is present at a higher concentration than 4-
91 (see Table 3). The major MeSO2-CBs
were 4-87 and 4-149. Both 4-87 and 4-149
were the predominant MeSO2-CBs in
human adipose tissue (40) and thus consis-
tent with the results ofthe present study. In
adipose and lung tissue from Yusho
patients, MeSO2-CB 4-87 was also the pre-
dominant PCB methyl sulfone, whereas a
quite different profile was reported in the
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Figure 5. Concentrations oftotal chlorinated biphenyls (CBs) and sum of CB methyl sulfones in human milk
sampled 1972-1992.
control sample with 4-MeSO2-2,5,4'-triCB
as the dominating and 4-MeSO2-2,5,2',4'-
CB (4-49) occurring in second highest level
(20). A different profile of MeSO2-CBs is
found in tissues of grey seal, otter, and
mink (7,18). In these species 3-MeSO2-
2,5,2',4',5'-pentaCB, originating from CB-
101, is the predominant PCB methyl sul-
fone. The results indicated differences in
exposure and/or metabolism of DDE and
PCBs, which may be ofimportance in pos-
sible toxic effects ofthese compounds.
The concentrations of MeSO2-DDE
and MeSO2-PCB in milk decreased during
the time course studied, in accordance with
the previously reported decline of DDT,
DDE and PCB in Swedish human milk
(35,36; in preparation). In a study of milk
from an occupationally exposed mother, a
dedine in the concentration of PCB, from
14,000 to 3700 ng/g lipids, and ofMeSO2-
PCB, from 590 to 150 ng/g lipids, during
16 months of milk excretion was reported
(44). At the time of that study, MeSO2-
PCB congener-specific analysis was not pos-
sible. However, the concentration of
MeSO2-PCB was estimated to 0.05 of the
PCB concentration. In the present investi-
gation the concentration ratios of MeSO2-
PCB relative to PCB were 0.009-0.004 and
declined during the 20 years studied. In a
Japanese study, correponding ratios in adi-
pose tissues were 0.02 and 0.04 from two
control persons and 0.004 and 0.006 from
two Yoshu patients (23). The profile ofthe
MeSO2-PCB in these samples differed from
the profile in Swedish human milk. In the
present study the congeners with 5 and 6
chlorine in the molecule dominated, while
in Japanese adipose tissue the lower chlori-
nated congeners were the dominating
MeSO2-CBs. In Swedish blood plasma, the
profile ofMeSO2-PCB is similar to that in
the milk (Weistrand and Noren, in prepara-
tion). Approximately twice as much 4-
MeSO2-CBs are present in the milk as are
3-MeSO2-CBs. The latter type of metabo-
lites have recently been reported as potent
inducers of several hepatic microsomal
drug-metabolizing enzymes while the 4-
MeSO2-CBs congeners tested were inactive
(45). On the other hand, certain 4-MeSO2-
CBs are strongly retained in lung bronchial
mucosa due to their binding to uteroglobin-
like macromolecules in the Clara cells (9).
It is also supposed that the chronic lung
dysfunction symptoms in Yusho patients
may have been caused by MeSO2-PCB
(46). It may thus be emphasized that the
MeSO2-CBs are also ofpotential toxicolog-
ical importance and the presence of these
PCB metabolites in human milk cannot be
neglected. Further studies of their toxico-
logical role are needed.
The data show that restrictions on the
use ofDDT and PCBs have led to decreased
levels ofthese compounds and their methyl
sulfone metabolites in human milk. The pre-
sent study is a first attempt at congener-spe-
cific analysis ofMeSO2 DDE and MeSO2-
PCB in milk, and it should be followed up
byanalysis ofother matrices ofhuman tissue
to investigate specific retention.
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